uk

Medscape

Medscape InDiscussion: CAR T-Cell Therapy

Science EN ↓ Епізодів: 6

Listen to Medscape InDiscussion: CAR T-Cell Therapy, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987065). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Обов'язково відвідайте сайт подкасту та підтримайте його автора: www.medscape.com

Автор

Medscape

Категорія

Science

Сайт подкасту

www.medscape.com

Останній епізод

12 вер 2023

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Завантажити з Google Play Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,7+ iOS незабаром

Епізоди

The Future of CAR T-cell Therapy 12.09.2023

Join Drs Amelia Langston and Frederick Locke as they discuss the future of CAR T-cell therapy research and treatment. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987070). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resou...

CAR T-Cell Therapy for Multiple Myeloma 10.08.2023

Join Drs Amelia Langston and Jonathan L. Kaufman, MD, as they discuss current CAR–T cell for B-cell lymphomas as leading researchers and practitioners in the field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987069). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is inten...

CAR T-Cell Therapy for B-Cell Lymphomas 11.07.2023

Join Drs Amelia Langston and Loretta Nastoupil as they discuss current CAR T-cell therapy for B-cell lymphomas as leading researchers and practitioners in the field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987068). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is inte...

CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia 13.06.2023

Join Drs Amelia Langston and Bijal Shah as they discuss CAR T-cell therapy for B-cell acute lymphoblastic leukemia, including clinical trials and real-world experience from their centers. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987067). The topics and discussions are planned, produced, and reviewed independently of advertisers...

Monitoring and Management of CAR T-Cell Therapy Complications 11.05.2023

Join Drs Amelia Langston and Jean Koff as they discuss the monitoring and management of complications before, during, and after CAR T therapy. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987066). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US health...

When Is CAR T-Cell Therapy the Answer? 11.05.2023

Drs Amelia Langston and Melody Smith provide an overview of CAR T-cell therapy, the products available, potential complications, and what's next in this rapidly advancing field. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987065). The topics and discussions are planned, produced, and reviewed independently of advertisers. This pod...

Слухайте подкаст Medscape InDiscussion: CAR T-Cell Therapy у Replaio

Радіо та подкасти в одному застосунку - безкоштовно й без реєстрації. Встановіть уже сьогодні та не пропустіть запуск

Завантажити з Google Play

Replaio не є видавцем подкастів; назви шоу, обкладинки та аудіо належать їхнім авторам і поширюються через публічні RSS-канали